Imexpharm

Imexpharm P/CF

The P/CF (Price-to-Cash-Flow Ratio) of Imexpharm (IMP.VN) as of Oct 26, 2026 is 151.82. In the previous year, P/CF (Price-to-Cash-Flow Ratio) was 38.03 — a change of 299.23% (higher).

P/CF

151.82

YoY

299.23%

Last updated:

P/CF (Price-to-Cash-Flow Ratio) of Imexpharm is 2025 151.82 . P/CF (Price-to-Cash-Flow Ratio) of Imexpharm was 2024 38.03 . It decreases by 299.23% higher compared to the previous year.

The Imexpharm P/CF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/CF
Date
P/CF
Jan 1, 2018
62.26 VND
Jan 1, 2019
123.50 VND
Jan 1, 2020
112.42 VND
Jan 1, 2021
35.01 VND
Jan 1, 2022
21.72 VND
Jan 1, 2023
-203.21 VND
Jan 1, 2024
38.03 VND
Jan 1, 2025
151.82 VND
The Imexpharm P/CF history
YEARP/CFYoY
151.82+299.23%
38.03-118.71%
-203.21-1,035.49%
21.72-37.96%
35.01-68.86%
112.42-8.97%
123.50+98.37%
62.26-26.41%
84.60-12.92%
97.15-47.08%
183.58-65.17%
527.04—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Imexpharm Stock analysis

What does Imexpharm do? Imexpharm Corp manufactures and trades pharmaceuticals, medicinal chemicals, and botanical products, including antiseptics, traditional medicine, medical equipment, cosmetics, and supplemental food and drinks. The company provides packaging and warehousing services specifically for pharmaceutical storage. It also cultivates medicinal herbs. Imexpharm Corp serves the pharmaceutical industry and healthcare sector through its manufacturing, import, export, and trade operations, targeting businesses requiring medicinal products and services. The company's revenue streams include the sale of manufactured pharmaceuticals, imported and exported goods, and services such as packaging and warehousing. Its customers are businesses in the healthcare sector, including distributors and retailers of pharmaceuticals, medical equipment, and related products. The firm's operations span manufacturing, import, export, and trade, with additional services supporting the pharmaceutical supply chain. Imexpharm Corp's product portfolio covers a wide range of medicinal and health-related items, from antiseptics to supplemental food and drinks. The company's involvement in medicinal herb cultivation supports its production of traditional medicine and herbal-based products. This vertical integration enhances its ability to supply comprehensive solutions to healthcare businesses. Imexpharm is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Imexpharm stock

P/CF (Price-to-Cash-Flow Ratio) of Imexpharm is 151.82 in 2025.

P/CF (Price-to-Cash-Flow Ratio) of Imexpharm changed from 38.03 to 151.82, representing a 299.23% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/CF (Price-to-Cash-Flow Ratio) Imexpharm since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Cash-Flow ratio measures the stock price relative to operating cash flow per share. Unlike P/E, it is harder to manipulate as cash flow is less subject to accounting adjustments.

P/CF = Stock Price / Operating Cash Flow per Share

To evaluate P/CF (Price-to-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/CF (Price-to-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/CF (Price-to-Cash-Flow Ratio)'s Imexpharm with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Imexpharm

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Imexpharm